[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356884-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356884-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","immune-landscape-of-gingivo-buccal-oral-cancer-indicates-high-enrichment-of-immune-related-gene-sets-in-tumors","Immune landscape of gingivo-buccal oral cancer indicates high enrichment of immune-related gene sets in tumors","","Oral squamous cell carcinoma of the gingivo-buccal region (OSCC-GB) shows urgent need for precision therapies due to molecular heterogeneity and subtype differences. Bulk RNA-seq was performed on tumor and adjacent normal tissues from 72 OSCC-GB patients, plus leukoplakia from 25 with concurrent lesions. Results show EMT, angiogenesis, and cell-cycle activation; enhanced glycolysis and reduced oxidative phosphorylation consistent with the Warburg effect. Gene set enrichment reveals two immune-related subtypes, with a majority exhibiting higher immune infiltration and potential immune checkpoint inhibitor responsiveness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immune-landscape-of-gingivo-buccal-oral-cancer-indicates-high-enrichment-of-immune-related-gene-sets-in-tumors/356884/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immune-landscape-of-gingivo-buccal-oral-cancer-indicates-high-enrichment-of-immune-related-gene-sets-in-tumors/356884.png","ImageObject",300,407,{"name":42,"@type":43},"Stanford","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What motivated the study of OSCC-GB?","Question",{"text":63,"@type":64},"OSCC-GB lacks sufficient molecular characterization, and precision therapy requires evaluating molecular heterogeneity and subtyping, including site-specific immune profiling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data and samples were analyzed?",{"text":68,"@type":64},"The study used bulk RNA-seq on tumor and adjacent normal tissues from 72 OSCC-GB patients and leukoplakia tissue from 25 patients with concurrent leukoplakia.",{"name":70,"@type":61,"acceptedAnswer":71},"What immune-related findings emerged from gene set enrichment?",{"text":72,"@type":64},"Gene set enrichment identified two molecular subtypes; the larger subtype showed higher immune cell infiltration and suggested potential responsiveness to immune checkpoint inhibitors, while the other subtype showed lower enrichment in immune-related gene sets.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356884,1790935707,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Das et al. Molecular Medicine (2026) 32:79 Molecular Medicine  \n[https://doi.org/10.1186/s10020-026-01473-w](https://doi.org/10.1186/s10020-026-01473-w)  \nRESEARCH Open Access  \nImmune landscape of gingivo-buccal oral cancer indicates high enrichment of immunerelated gene sets in tumors of a large proportion of patients  \nDebodipta Das1*, Arindam Maitra2, Chinmay K. Panda3, Sandip Ghose4, Bidyut Roy5, Rajiv Sarin6 and Partha P. Majumder5,7*  \nAbstract  \nBackground Oral squamous cell carcinoma of the gingivo-buccal region (OSCC-GB) is the most common cancer among males in India and the second most prevalent cancer overall. Therefore, there is an urgent need to develop precision therapies based on an evaluation of molecular heterogeneity and molecular subtyping.  \nMethods We performed bulk RNA-Seq on tumor and adjacent normal tissue samples from 72 OSCC-GB patients, as well as leukoplakia (precancerous) tissue from 25 patients with concurrent leukoplakia.  \nResults Analysis of our data revealed activation of epithelial-mesenchymal transition, angiogenesis, and cell-cycle pathways. Metabolic analysis revealed enhanced glycolysis and reduced oxidative phosphorylation, consistent  \nwith the Warburg effect. Gene set enrichment analysis identified two distinct molecular subtypes, one of which comprises 76 .4% of the patients. This subtype is characterized by higher immune cell infiltration, suggesting potential responsiveness to immune checkpoint inhibitors. Additionally, CD226, CD38, and KBTBD8 were identified as potential biomarkers for patient classification (average classification accuracy of 86 . 1%) and were validated in an independent cohort. The smaller number of patients (23 . 6%) who comprised the second subtype showed lower enrichment in immune-related gene sets. Pre-malignant leukoplakia tissues showed significantly higher M1 macrophages and CD4 + T-cells compared to normal tissues, indicating an activated host defense mechanism and potential for early intervention. TCGA-HNSC tumors also exhibited molecular heterogeneity; some subtypes were similar to OSCC-GB tumors and revealed shared enrichment of glycolysis and immune-related pathways.  \nConclusions Our findings provide critical insights into the molecular and immune landscape of OSCC-GB, paving the way for improved therapeutic strategies and immunotherapy approaches.  \nKeywords Gingivo-buccal oral cancer, Leukoplakia, Transcriptomics, Immunotherapy, Gene markers  \n*Correspondence: Debodipta Das [debodipta@gmail.com](debodipta@gmail.com)[ ](debodipta@gmail.com)Partha P. Majumder [parmaj2023@gmail.com](parmaj2023@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nDas et al. Molecular Medicine (2026) 32:79  \nBackground  \nOral squamous cell carcinoma (OSCC) is the most prevalent malignancy of the oral cavity, with","cbCaiqwNx1pUVaUF","https://ap.wps.com/l/cbCaiqwNx1pUVaUF","pdf",5452140,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Study rationale and context\n## Transcriptomic and immune-related features","[{\"question\":\"What motivated the study of OSCC-GB?\",\"answer\":\"OSCC-GB lacks sufficient molecular characterization, and precision therapy requires evaluating molecular heterogeneity and subtyping, including site-specific immune profiling.\"},{\"question\":\"What data and samples were analyzed?\",\"answer\":\"The study used bulk RNA-seq on tumor and adjacent normal tissues from 72 OSCC-GB patients and leukoplakia tissue from 25 patients with concurrent leukoplakia.\"},{\"question\":\"What immune-related findings emerged from gene set enrichment?\",\"answer\":\"Gene set enrichment identified two molecular subtypes; the larger subtype showed higher immune cell infiltration and suggested potential responsiveness to immune checkpoint inhibitors, while the other subtype showed lower enrichment in immune-related gene sets.\"}]","Immune landscape of gingivo-buccal oral cancer indicates high enrichment of immune-related gene sets in tumors | PDF",1790127930,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1951163ae61474d1aa61bd54058f2a2.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd932726bdf67f8b5767dc0f4147c893.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79e1651574a5078100be81adcbeef3b8.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5506966370be3dd5c866c808563dcec1.webp",980,1306]